Caresyntax secures $180M to build AI-powered 'Android of robotic surgery'
Caresyntax, a leading company in the healthcare technology sector, has recently raised an impressive $180 million in funding. The funding will be used to further develop their open AI platform for surgery, with the ambitious goal of becoming the 'Android of robotic surgery'.
This significant investment will enable Caresyntax to leverage advanced artificial intelligence technologies to revolutionize the field of robotic surgery. By building an open platform that is accessible to all, they aim to democratize surgical technologies and improve patient outcomes across the globe.
